Uniphar PLC UPR
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- €4.29
- Day Range
- €4.20–4.33
- 52-Week Range
- €3.38–4.98
- Bid/Ask
- €0.00 / €4.90
- Shares Outstanding
- 259.57M
- Market Cap
- €1.11B
- Volume/Avg
- 68,372 / 366,242
Key Statistics
- Price/Earnings (Normalized)
- 14.62
- Price/Sales
- 0.37
- Dividend Yield (Trailing)
- 0.47%
- Dividend Yield (Forward)
- 0.47%
- Total Yield
- 3.62%
Company Profile
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
- Sector
- Healthcare
- Industry
- Medical Distribution
- Stock Style Box
- Small Core
- Total Number of Employees
- 3,581
- Website
- https://www.uniphar.ie
Valuation
|
Metric
|
UPR
|
|---|---|
Price/Earnings (Normalized) | 14.62 |
Price/Book Value | 2.74 |
Price/Sales | 0.37 |
Price/Cash Flow | 17.75 |
Price/Earnings
UPR
Financial Strength
|
Metric
|
UPR
|
|---|---|
Quick Ratio | 0.61 |
Current Ratio | 0.99 |
Interest Coverage | 3.90 |
Quick Ratio
UPR
Profitability
|
Metric
|
UPR
|
|---|---|
Return on Assets (Normalized) | 4.14% |
Return on Equity (Normalized) | 16.70% |
Return on Invested Capital (Normalized) | 9.43% |
Return on Assets
UPR
Medical Distribution Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| McKesson Corp
MCK
| LOCK|rPr#b! | LOCK|mN>@ | $101B | |||
| Cencora Inc
COR
| LOCK|?#yCZbx | LOCK|@$qGz | $60B | |||
| Cardinal Health Inc
CAH
| LOCK|d$Nzy%Y | LOCK|wgyb | $55B | |||
| Sigma Healthcare Ltd
SIGGF
| — | LOCK|nCF@ | $24B | |||
| Henry Schein Inc
HSIC
| LOCK|q@%V$GD | LOCK|NQC# | $10B | |||
| Shanghai Pharmaceuticals Holding Co Ltd ADR
SHPMY
| — | LOCK|Qw | $8B | |||
| Sinopharm Group Co Ltd
SHTDF
| — | LOCK|ZCP | $7B | |||
| Sinopharm Group Co Ltd ADR
SHTDY
| — | LOCK|?CQ | $7B | |||
| Amplifon SpA ADR
AMFPY
| — | LOCK|<t | $4B | |||
| Amplifon SpA Az nom Post Frazionamento
AMFPF
| — | LOCK|qK | $4B |
United States